SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral …
SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the …
Company implementing significant cost reduction plan in the U.S. due to results in late-stage pamrevlumab pancreatic cancer trials, including a reduction of U.S. workforce by approximately 75% Focus R&D investment on FG-3246 and PET46, a first-in-class …
Q1 Financial Highlights: Revenue Increased Over 33% Year Over Year to $40 Million Reported Expanded Gross Margin and Achieved Non-GAAP Net Income Generated $3.4 Million of Operating Cash Flow Company to host conference call tomorrow, August 7th, at 10: …
Completed enrollment in batoclimab pivotal Myasthenia Gravis (MG) trial; top-line results and initiation of a potentially registrational program for IMVT-1402 on track for fiscal year end (March 31, 2025) Progressed development of lead asset IMVT-1402 with …
Annualized recurring revenue (“ARR”) of $816 million, an increase of 9% year-over-year Total revenue of $208 million, up 9% year-over-year; Product subscriptions revenue of $200 million, up 10% year-over-year GAAP operating income of $7 million; non-GAAP …
MIAMI BEACH, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition company, today announced that it received a notice (the “Notice”) from the Listing …
DENVER, Aug. 06, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (Nasdaq: EVCM) (the “Company”), a leading provider of SaaS solutions for service SMBs, announced today that it has appointed Ryan Siurek as chief financial officer (CFO), effective September 6, …
FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2024. Recent …
SEATTLE, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Xylitol, also known as birch sugar, wood sugar, or birch bark extract, is a sugar substitute product commonly found in foods labeled “sugar free”, “no sugar added”, “reduced sugar”, “diabetic friendly” and other …
EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the second quarter of …
Record quarterly GAAP and Non-GAAP operating margins Raises 2024 revenue and Non-GAAP operating margin guidance Continuing to invest in the fast-growing Unified SASE and Security Operations markets Second Quarter 2024 Highlights Total revenue of $1.43 …
Highlights Second quarter revenue grew 15% year-over-year to $212 million, driven by Prenatal (25%), Pharmacogenomics (22%), and Hereditary Cancer (19%). Second quarter GAAP earnings per share improved to $(0.41) from $(1.42) in the second quarter of 2023; …
RICHMOND, Va., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced financial results for the second quarter …
INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Deuxième Trimestre et Premier Semestre 2024 Soumission réglementaire auprès de la complétée, l'approbation aux États-Unis est en bonne voie pour la fin de 2024 …
SUGAR LAND, Texas, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today …
FORT WAYNE, Ind., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the second quarter of the fiscal year ending August 3, 2025 at 8:00 a.m. Eastern Time on Wednesday, …
-- VAX-31 Adult Phase 1/2 Study Topline Safety, Tolerability and Immunogenicity Data Expected in September 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Results, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 Infant Phase 2 …
-- Total Revenues More Than Doubled, Reaching a Record High Significant Growth in Adjusted EBITDA Reflects Enhanced Operational Efficiency and Profitability -- EL MONTE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“ …
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.cfm. Who: Adena Friedman, Chair and CEO, Nasdaq …
